The Anticonvulsant Effects of Ketogenic Diet on Epileptic Seizures and Potential Mechanisms

Yifan Zhang, Jingwei Xu, Kun Zhang, Wei Yang, Bingjin Li, Yifan Zhang, Jingwei Xu, Kun Zhang, Wei Yang, Bingjin Li

Abstract

Background: Epilepsy is a syndrome of brain dysfunction induced by the aberrant excitability of certain neurons. Despite advances in surgical technique and anti-epileptic drug in recent years, recurrent epileptic seizures remain intractable and lead to a serious morbidity in the world. The ketogenic diet refers to a high-fat, low-carbohydrate and adequate-protein diet. Currently, its beneficial effects on epileptic seizure reduction have been well established. However, the detailed mechanisms underlying the anti-epileptic effects of ketogenic diet are still poorly understood. In this article, the possible roles of ketogenic diet on epilepsy were discussed.

Methods: Data was obtained from the websites including Web of Science, Medline, Pubmed, Scopus, based on these keywords: "Ketogenic diet" and "epilepsy".

Results: As shown in both clinical and basic studies, the therapeutic effects of ketogenic diet might involve neuronal metabolism, neurotransmitter function, neuronal membrane potential and neuron protection against ROS.

Conclusion: In this review, we systematically reviewed the effects and possible mechanisms of ketogenic diet on epilepsy, which may optimize the therapeutic strategies against epilepsy.

Keywords: Epilepsy; GABA; animal; ketogenic diet; neuron; seizure.

Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

References

    1. Liu W., Ge T., Pan Z., Leng Y., Lv J., Li B. The effects of herbal medicine on epilepsy. Oncotarget. 2017;8(29):48385–48397.
    1. Nazıroğlu M. TRPV1 Channel: A potential drug target for treating epilepsy. Curr. Neuropharmacol. 2015;13(2):239–247. []. [PMID: 26411767].
    1. Celli R., Santolini I., Guiducci M., van Luijtelaar G., Parisi P., Striano P., Gradini R., Battaglia G., Ngomba R.T., Nicoletti F. The α2δ subunit and absence epilepsy: Beyond calcium channels? Curr. Neuropharmacol. 2017;15(6):918–925.
    1. Mortality G.B. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;385(9963):117–171. [ 10.1016/S0140-6736(14)61682-2]. [PMID: 25530442].
    1. Brodie M.J., Elder A.T., Kwan P. Epilepsy in later life. Lancet Neurol. 2009;8(11):1019–1030. []. [PMID: 19800848].
    1. Pandolfo M. Genetics of epilepsy. Semin. Neurol. 2011;31(5):506–518. []. [PMID: 22266888].
    1. Frey H.H. Anticonvulsant drugs used in the treatment of epilepsy. Probl. Vet. Med. 1989;1(4):558–577. [PMID: 2520134].
    1. Eadie M.J. Shortcomings in the current treatment of epilepsy. Expert Rev. Neurother. 2012;12(12):1419–1427. [http://dx.doi. org/10.1586/ern.12.129]. [PMID: 23237349].
    1. Zhang Y., Liu C., Zhao Y., Zhang X., Li B., Cui R., Zhang Y., Liu C., Zhao Y., Zhang X., Li B., Cui R. The effects of calorie restriction in depression and potential mechanisms. Curr. Neuropharmacol. 2015;13(4):536–542.
    1. Levy R.G., Cooper P.N., Giri P. Ketogenic diet and other dietary treatments for epilepsy. Cochrane Database Syst. Rev. 2012;(3):CD001903. [PMID: 22419282].
    1. IJff D.M., Postulart D., Lambrechts D.A., Majoie M.H., de Kinderen R.J., Hendriksen J.G., Evers S.M., Aldenkamp A.P. Cognitive and behavioral impact of the ketogenic diet in children and adolescents with refractory epilepsy: A randomized controlled trial. Epilepsy Behav. 2016;60:153–157. [ j.yebeh.2016.04.033]. [PMID: 27206235].
    1. Kang H.C., Chung D.E., Kim D.W., Kim H.D. Early- and late-onset complications of the ketogenic diet for intractable epilepsy. Epilepsia. 2004;45(9):1116–1123. [. 0013-9580.2004.10004.x]. [PMID: 15329077].
    1. Sharma S., Sankhyan N., Gulati S., Agarwala A. Use of the modified Atkins diet for treatment of refractory childhood epilepsy: a randomized controlled trial. Epilepsia. 2013;54(3):481–486. []. [PMID: 23294191].
    1. Kossoff E.H., Rowley H., Sinha S.R., Vining E.P. A prospective study of the modified Atkins diet for intractable epilepsy in adults. Epilepsia. 2008;49(2):316–319. []. [PMID: 17919301].
    1. Miranda M.J., Mortensen M., Povlsen J.H., Nielsen H., Beniczky S. Danish study of a modified Atkins diet for medically intractable epilepsy in children: can we achieve the same results as with the classical ketogenic diet? Seizure. 2011;20(2):151–155. []. [PMID: 21126887].
    1. Kim J.A., Yoon J.R., Lee E.J., Lee J.S., Kim J.T., Kim H.D., Kang H.C. Efficacy of the classic ketogenic and the modified Atkins diets in refractory childhood epilepsy. Epilepsia. 2016;57(1):51–58. []. [PMID: 26662710].
    1. Kim Y.M., Vaidya V.V., Khusainov T., Kim H.D., Kim S.H., Lee E.J., Lee Y.M., Lee J.S., Kang H.C. Various indications for a modified Atkins diet in intractable childhood epilepsy. Brain Dev. 2012;34(7):570–575. [. 2011.09.013]. [PMID: 22001499].
    1. Rho J.M., Anderson G.D., Donevan S.D., White H.S. Acetoacetate, acetone, and dibenzylamine (a contaminant in l-(+)-beta-hydroxybutyrate) exhibit direct anticonvulsant actions in vivo. Epilepsia. 2002;43(4):358–361. []. [PMID: 11952765].
    1. Likhodii S.S., Serbanescu I., Cortez M.A., Murphy P., Snead O.C., III, Burnham W.M. Anticonvulsant properties of acetone, a brain ketone elevated by the ketogenic diet. Ann. Neurol. 2003;54(2):219–226. []. [PMID: 12891674].
    1. Gasior M., Hartman A.L., Rogawski M.A. The anticonvulsant activity of acetone does not depend upon its metabolites. Epilepsia. 2008;49(5):936–937. [. 01518_3.x]. [PMID: 18454785].
    1. Gasior M., French A., Joy M.T., Tang R.S., Hartman A.L., Rogawski M.A. The anticonvulsant activity of acetone, the major ketone body in the ketogenic diet, is not dependent on its metabolites acetol, 1,2-propanediol, methylglyoxal, or pyruvic acid. Epilepsia. 2007;48(4):793–800. []. [PMID: 17386058].
    1. Seymour K.J., Bluml S., Sutherling J., Sutherling W., Ross B.D. Identification of cerebral acetone by 1H-MRS in patients with epilepsy controlled by ketogenic diet. MAGMA. 1999;8(1):33–42. [PMID: 10383091].
    1. Spilioti M., Pavlou E., Gogou M., Katsanika I., Papadopoulou-Alataki E., Grafakou O., Gkampeta A., Dinopoulos A., Evangeliou A. Valproate effect on ketosis in children under ketogenic diet. Eur. J. Paediatr. Neurol. 2016;20(4):555–559. [http://dx.doi. org/10.1016/j.ejpn.2016.04.003]. [PMID: 27117552].
    1. Greene A.E., Todorova M.T., Seyfried T.N. Perspectives on the metabolic management of epilepsy through dietary reduction of glucose and elevation of ketone bodies. J. Neurochem. 2003;86(3):529–537. []. [PMID: 12859666].
    1. Fisher R.S., van Emde B.W., Blume W., Elger C., Genton P., Lee P., Engel J., Jr Epileptic seizures and epilepsy: definitions proposed by the international league against epilepsy (ILAE) and the international bureau for epilepsy (IBE). Epilepsia. 2005;46(4):470–472. []. [PMID: 15816939].
    1. Cheng C.M., Kelley B., Wang J., Strauss D., Eagles D.A., Bondy C.A. A ketogenic diet increases brain insulin-like growth factor receptor and glucose transporter gene expression. Endocrinology. 2003;144(6):2676–2682. []. [PMID: 12746332].
    1. Becker F., Schubert J., Weckhuysen S., Suls A., Grüninger S., Korn-Merker E., Hofmann-Peters A., Sperner J., Cross H., Hallmann K., Elger C.E., Kunz W.S., Madeleyen R., Lerche H., Do Weber Y.G. Glut1 (glucose transporter type 1) defects exist in epilepsy patients responding to a ketogenic diet? Epilepsy Res. 2015;114:47–51. [. 04.012]. [PMID: 26088884].
    1. Qian F., Tang F.R. Metabotropic glutamate receptors and interacting proteins in epileptogenesis. Curr. Neuropharmacol. 2016;14(5):551–562. [ 1142228]. [PMID: 27030135].
    1. Cullingford T.E., Eagles D.A., Sato H. The ketogenic diet upregulates expression of the gene encoding the key ketogenic enzyme mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase in rat brain. Epilepsy Res. 2002;49(2):99–107. [ 10.1016/S0920-1211(02)00011-6]. [PMID: 12049798].
    1. Fraser D.D., Whiting S., Andrew R.D., Macdonald E.A., Musa-Veloso K., Cunnane S.C. Elevated polyunsaturated fatty acids in blood serum obtained from children on the ketogenic diet. Neurology. 2003;60(6):1026–1029. [. 0000049974.74242.C6]. [PMID: 12654976].
    1. Wexler I.D., Hemalatha S.G., McConnell J., Buist N.R., Dahl H.H., Berry S.A., Cederbaum S.D., Patel M.S., Kerr D.S. Outcome of pyruvate dehydrogenase deficiency treated with ketogenic diets. Studies in patients with identical mutations. Neurology. 1997;49(6):1655–1661. []. [PMID: 9409363].
    1. Lionel A.C., Monfared N., Scherer S.W., Marshall C.R., Mercimek-Mahmutoglu S. MED23-associated refractory epilepsy successfully treated with the ketogenic diet. Am. J. Med. Genet. A. 2016;170(9):2421–2425. []. [PMID: 27311965].
    1. Bough K.J., Gudi K., Han F.T., Rathod A.H., Eagles D.A. An anticonvulsant profile of the ketogenic diet in the rat. Epilepsy Res. 2002;50(3):313–325. [ 00086-4]. [PMID: 12200222].
    1. Erecińska M., Nelson D., Daikhin Y., Yudkoff M. Regulation of GABA level in rat brain synaptosomes: fluxes through enzymes of the GABA shunt and effects of glutamate, calcium, and ketone bodies. J. Neurochem. 1996;67(6):2325–2334. [ 10.1046/j.1471-4159.1996.67062325.x]. [PMID: 8931464].
    1. Wang Z.J., Bergqvist C., Hunter J.V., Jin D., Wang D.J., Wehrli S., Zimmerman R.A. In vivo measurement of brain metabolites using two-dimensional double-quantum MR spectroscopy--exploration of GABA levels in a ketogenic diet. Magn. Reson. Med. 2003;49(4):615–619. []. [PMID: 12652530].
    1. Dahlin M., Elfving A., Ungerstedt U., Amark P. The ketogenic diet influences the levels of excitatory and inhibitory amino acids in the CSF in children with refractory epilepsy. Epilepsy Res. 2005;64(3):115–125. [. 03.008]. [PMID: 15961283].
    1. Yudkoff M., Daikhin Y., Horyn O., Nissim I., Nissim I. Ketosis and brain handling of glutamate, glutamine, and GABA. Epilepsia. 2008;49(Suppl. 8):73–75. [. 2008.01841.x]. [PMID: 19049594].
    1. Al-Mudallal A.S., LaManna J.C., Lust W.D., Harik S.I. Diet-induced ketosis does not cause cerebral acidosis. Epilepsia. 1996;37(3):258–261. [. x]. [PMID: 8598184].
    1. Szot P., Weinshenker D., Rho J.M., Storey T.W., Schwartzkroin P.A. Norepinephrine is required for the anticonvulsant effect of the ketogenic diet. Brain Res. Dev. Brain Res. 2001;129(2):211–214. []. [PMID: 11506865].
    1. Masino S.A., Li T., Theofilas P., Sandau U.S., Ruskin D.N., Fredholm B.B., Geiger J.D., Aronica E., Boison D. A ketogenic diet suppresses seizures in mice through adenosine A1 receptors. J. Clin. Invest. 2011;121(7):2679–2683. [ JCI57813]. [PMID: 21701065].
    1. Juge N., Gray J.A., Omote H., Miyaji T., Inoue T., Hara C., Uneyama H., Edwards R.H., Nicoll R.A., Moriyama Y. Metabolic control of vesicular glutamate transport and release. Neuron. 2010;68(1):99–112. [. 002]. [PMID: 20920794].
    1. Kawamura M., Jr, Ruskin D.N., Masino S.A. Metabolic autocrine regulation of neurons involves cooperation among pannexin hemichannels, adenosine receptors, and KATP channels. J. Neurosci. 2010;30(11):3886–3895. [ JNEUROSCI.0055-10.2010]. [PMID: 20237259].
    1. Tanner G.R., Lutas A., Martínez-François J.R., Yellen G. Single K ATP channel opening in response to action potential firing in mouse dentate granule neurons. J. Neurosci. 2011;31(23):8689–8696. []. [PMID: 21653873].
    1. Manjarrez-Marmolejo J., Franco-Pérez J. Gap junction blockers: An overview of their effects on induced seizures in animal models. Curr. Neuropharmacol. 2016;14(7):759–771. [http://dx.doi. org/10.2174/1570159X14666160603115942]. [PMID: 27262601].
    1. Maalouf M., Sullivan P.G., Davis L., Kim D.Y., Rho J.M. Ketones inhibit mitochondrial production of reactive oxygen species production following glutamate excitotoxicity by increasing NADH oxidation. Neuroscience. 2007;145(1):256–264. [ 10.1016/j.neuroscience.2006.11.065]. [PMID: 17240074].
    1. Milder J.B., Liang L.P., Patel M. Acute oxidative stress and systemic Nrf2 activation by the ketogenic diet. Neurobiol. Dis. 2010;40(1):238–244. []. [PMID: 20594978].
    1. Kim D.Y., Davis L.M., Sullivan P.G., Maalouf M., Simeone T.A., van Brederode J., Rho J.M. Ketone bodies are protective against oxidative stress in neocortical neurons. J. Neurochem. 2007;101(5):1316–1326. [. 2007.04483.x]. [PMID: 17403035].

Source: PubMed

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren